Global and United States Healthcare Contract Research Organizations (CRO) Services Market Report & Forecast 2022-2028

SKU ID : QYR-20913892 | Publishing Date : 09-May-2022 | No. of pages : 101

Healthcare Contract Research Organizations (CRO) Service provides support services to the pharmaceutical, biotechnology, and medical device companies throughout the development of the product. Pharmaceutical and biotechnology companies and the medical device industry require various testing services such as preclinical services, clinical research services, analytical testing services, bio analytical testing services, and regulatory services.
Market Analysis and Insights: Global and United States Healthcare Contract Research Organizations (CRO) Services Market
This report focuses on global and United States Healthcare Contract Research Organizations (CRO) Services market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Healthcare Contract Research Organizations (CRO) Services market size is estimated to be worth US$ 42710 million in 2022 and is forecast to a readjusted size of US$ 55780 million by 2028 with a CAGR of 4.6% during the review period. Fully considering the economic change by this health crisis, by Type, Early Phase Development accounting for % of the Healthcare Contract Research Organizations (CRO) Services global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Medical Device Companies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Healthcare Contract Research Organizations (CRO) Services market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Healthcare Contract Research Organizations (CRO) Services Scope and Market Size
Healthcare Contract Research Organizations (CRO) Services market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Healthcare Contract Research Organizations (CRO) Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Healthcare Contract Research Organizations (CRO) Services market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Early Phase Development
Laboratory Services
Consulting Services
Clinical Research Services
Segment by Application
Medical Device Companies
Pharmaceutical and Biopharmaceutical Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Charles River Laboratories Inc.
IQVIA Inc.
Laboratory Corporation of America Holdings
Parexel International Corporation
Icon Plc.
Pra Health Sciences
Syneos Health
Medpace
Wuxi Apptec
PPD Inc.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
PRICE
4350
8700

5075


  • market Reports market Reports